| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |